Home » Science and Research » 340B

Category: 340B

February 6, 2024 STAT Off 340B, Biotech, CDC, CMS, Congress, D.C. Diagnosis, drug prices, HHS, hospitals, Human Health, Joe Biden, Life Sciences, Medicare, Medicine, patents, PBMs, policy, Politics, public health, Science and Research, White House

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

February 2, 2024 STAT Off 340B, Biotech, Congress, drug prices, Human Health, Life Sciences, Medicare, Medicine, policy, Politics, Science and Research, STAT+

WASHINGTON — A bipartisan group of senators released a draft of legislation to resolve controversial…

November 2, 2023 STAT Off 340B, Biotech, drug prices, HHS, Human Health, Life Sciences, Medicare, Medicine, policy, Politics, Science and Research, STAT+, Supreme Court, White House

WASHINGTON — Medicare officials are moving forward with a plan to claw back money from certain…

July 7, 2023 STAT Off 340B, Biotech, drug pricing, hospitals, Human Health, Life Sciences, Medicare, Medicine, policy, Politics, Science and Research, STAT+, White House

WASHINGTON — Medicare is planning to send $9 billion in lump sum payments to more…

March 9, 2023 STAT Off 340B, advocacy, Biotech, drug pricing, hospitals, Human Health, Life Sciences, Medicare, Medicine, Pharma, Pharmaceuticals, policy, Politics, Science and Research

WASHINGTON — An unusual new alliance of the brand-drug lobby PhRMA and community health centers…

January 10, 2023 STAT Off 340B, Biotech, Congress, HHS, hospitals, Human Health, Life Sciences, Medicine, Pharmaceuticals, Politics, Science and Research, STAT+, White House

WASHINGTON — The Department of Health and Human Services will get to decide how to…

October 26, 2022 STAT Off 340B, advocacy, Biotech, drug pricing, First Opinion, Human Health, Life Sciences, Medicine, research, Science and Research

The 340B Drug Discount Program turns 30 on Nov. 4. This once-obscure drug access program…